|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 CAD | -1.75% |
|
-1.75% | -13.85% |
| 06:18pm | Thiogenesis Therapeutics' Treatment For Leigh Syndrome Receives FDA Rare Pediatric Disease Designation | MT |
| 06-17 | Thiogenesis Therapeutics Appoints Gilad Aharon to its Board | MT |
Chart: Technical Analysis
- Stock Market
- Stocks
- TTI Stock
- Charts Thiogenesis Therapeutics, Corp.
Select your edition
All financial news and data tailored to specific country editions
















